Weight Loss with GLP-1: Why Muscle Loss Is the Underestimated Side Effect
There is often a great sense of relief when the number on the scale finally goes down. GLP-1 medications like semaglutide or tirzepatide, better known as weight-loss injections, have transformed weight loss for many people: reduced appetite, faster results, and a new sense of control. But behind the visible weight loss lies a question that is often overlooked in public discourse: What exactly is the body losing? “Longevity pharmacist”Carole Holzhäuer explains this in this report.
GLP-1 therapies reduce not only fat mass but also lean body mass—including, among other things, muscle mass. Studies clearly demonstrate this. While the extent of this reduction varies depending on the study and context, it is clinically significant. At the same time, recent reviews emphasize that the true measure of treatment success should not be weight loss alone, but rather changes in body composition and the maintenance of physical function.
Losing weight doesn’t automatically mean better health
Weight loss is often equated with good health. But the body doesn’t distinguish between “good” and “bad” weight loss. If muscle mass is lost along with body weight, the consequences often don’t become apparent until later. Our muscle tissue isn’t just important for strength and stability. It’s also highly metabolically active and influences basal metabolic rate, blood sugar metabolism, and overall resilience.
This is precisely why muscle loss is more than just a cosmetic issue. Those who lose muscle mass burn less energy at rest. This can contribute to weight loss stalling later on or to a plateau setting in more quickly after the initial phase of success. At the same time, physical performance often declines—something that many people initially do not associate with the treatment.
What GLP-1 does in the body
GLP-1 medications primarily work by reducing food intake: appetite decreases, gastric emptying slows down, and many people eat significantly less than before. This effectively supports weight loss. At the same time, however, this also creates a risk: if protein intake is too low over an extended period and there is no targeted stimulus for muscle maintenance, the body does not rely solely on fat reserves.
More recent studies differentiate this more clearly than in the past. Some data show that fat mass decreases significantly more than lean mass under GLP-1 therapies and that overall body composition can actually improve. At the same time, the loss of lean mass remains a reality. It is precisely this aspect that deserves more attention, especially with long-term use or in people who already have limited muscle reserves.
Why protein, exercise, and micronutrients are no minor matter
Anyone who wants to lose weight successfully with GLP-1 should aim not only to make their body “lighter” but also to improve its functional stability. This cannot be achieved through calorie restriction alone. Three factors are crucial: sufficient protein, targeted exercise, and an adequate supply of micronutrients.
Protein is essential for maintaining muscle tissue. However, especially when experiencing a loss of appetite, people often consume too little of it because small portions quickly fill them up, and protein-rich foods are not always preferred during this phase. In addition, exercise—especially strength training or other muscle-stimulating activities—sends a key signal to the body to preserve existing muscle mass. The scientific literature therefore increasingly emphasizes that GLP-1 therapies should not be viewed in isolation but must be embedded within a nutrition and exercise strategy.
Micronutrients also play a role, albeit a less dramatic one. They are involved in energy production, muscle function, and recovery. If meals become very small or unbalanced, nutrient intake can tip out of balance faster than many people realize. In that case, successful weight loss does not automatically translate into improved health.
What Is often overlooked in everyday life
In everyday life, much of the focus is on what’s visible: clothing size, the scale, before-and-after photos. Less visible, however, are muscle loss, declining strength, or a slowing metabolism. That’s exactly why it’s worth taking a different look at the therapy. It’s not just “How much weight have I lost?” that matters, but also: How do I feel? How stable is my strength? How sustainable is my metabolism?
Current research is moving in exactly this direction. It no longer asks only about the number of pounds lost, but also about bodily function, muscle quality, and long-term metabolic health. Even new pharmacological approaches are already aiming to better balance fat loss and muscle preservation.
Conclusion
GLP-1 medications can be effective for weight loss. However, not all weight loss automatically translates to health benefits. If too much muscle mass is lost along with the fat, this has consequences for strength, metabolism, and long-term success. The crucial question, therefore, is not just whether weight is lost, but what body composition is preserved in the process. Successful weight loss is not measured solely in pounds, but in metabolic stability, function, and the preservation of body composition.

C&C Autorin aus Magdeburg
Carole Holzhäuer ist Apothekerin und Epigenetik-Coach – bekannt als „die Longevity-Apothekerin“. Sie verbindet modernes Wissen aus Pharmazie, Epigenetik und individueller Mikronährstoffberatung zu einem ganzheitlichen Ansatz für Gesundheit und gesundes Altern. Mit großer Leidenschaft erforscht sie, welche Mikronährstoffe, Präparate und Lebensumstände Einfluss auf Vitalität und Zellgesundheit haben. In ihrer Apotheke bietet sie u. a. individuelle Analysen zur personalisierten Beratung an, um Therapien individuell auf den Stoffwechsel abzustimmen.


